Skip to main content
Premium Trial:

Request an Annual Quote

Galileo Genomics Closes $5.2M in Financing

This article has been corrected from a previous version, to reflect the currency conversions between Canadian and US dollars.


NEW YORK, Feb. 25 - Galileo Genomics of Montreal said today it had closed CA$7.7 million, ($5.2 million) in new financing.


The financing came in the form of two rounds, the first a $CA4.7 million ($3.15 million) round led by HBM Bioventures of Zurich, with contributions from Investissement Desjardins of Montreal, BTF of Amsterdam, MVI of London, and BioFund of Helsinki; and the second a $CA3.0 million ($2.0 million) capital equipment-based financing with MM Venture Partners.


Galileo is building a population genomics database based on Quebecfounder populations, and is analyzing the database for common diseases.


The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.